Novo Nordisk Agrees To Cap Insulin Costs At $35 In Minn. Settlement Agreement
NEWARK, N.J. — Novo Nordisk Inc. and Minnesota reached an agreement in which the drug maker agreed to make its insulin XE "insulin" products available to consumers in Minnesota for no...To view the full article, register now.
Already a subscriber? Click here to view full article